WIRB-Copernicus Group Thought Leader to Speak at Industry Leading Biosafety Conferences

PRINCETON, N.J., July 28, 2014 – WIRB-Copernicus Group® (“WCGTM”), the world’s largest provider of regulatory and ethical review services for clinical research, announced today that Chris Jenkins, PhD, MPH, RBP, CHMM, the Company’s senior director of IBC Services and Biosafety Consulting, will be a presenter at the 2014 Campus Safety, Health and Environmental Management Association (CSHEMA) 61st Annual Conference being held July 25-30 in Palm Springs, CA. Dr. Jenkins will also be presenting at the Midwest Area Biosafety Network (MABioN) Symposium taking place August 4-6 in Columbia, MO.

Dr. Jenkins is responsible for overseeing research compliance at institutions with human gene transfer clinical trials, recombinant and synthetic DNA, and select agents and toxins. He oversees more than 200 Institutional Biosafety Committees (IBCs) in universities, private research institutes, and clinical settings.

At CSHEMA, Dr. Jenkins will be highlighting findings from an IBC survey and sharing best practices and trends from the data in a presentation entitled, “Institutional Biosafety Committees Practices Survey Results and Conclusions.” The session will be held on July 29 from 10:30-11:15 a.m. during Technical Session Block 3.

“Managing biological materials oversight in clinical research across the United States is a challenging endeavor for research institutions,” said Jenkins. “It is critical that we continue to educate our colleagues in order to ensure the protection of human subjects, the safety of their investigators and personnel, and the security of their laboratories and workspaces.”

A proud sponsor of this year’s conference, WCG BiosafetyTM will be partnering with CSHEMA and the Foundation of Hospital Art to paint a mural for the Barbara Sinatra Children’s Center at Eisenhower Medical Center. The event will take place at the conference hotel on July 29 from 7:30-9 a.m.

Located at booth 200 in the exhibit hall, WCG Biosafety will have leading authorities in biosafety, biosecurity, and bio-risk management available to discuss important topics in the biosafety industry.

During the MABioN symposium, Dr. Jenkins will participate in a session entitled, “Updates and Issues in Human Gene Transfer Biosafety Reviews” from 4:30-5:00 p.m. on August 5 at the Stoney Creek Conference Center.

About The WIRB-­‐Copernicus Group
The WIRB-Copernicus Group (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG’s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.

WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life.

For more information, please visit www.wcgclinical.com.

Download the Press Release
[wpdm_package id=’2354′]